Medical Equipment

Molecular Diagnostics Devices And Equipment Market Outlook 2025–2029: Emerging Opportunities and Key Drivers

December 4, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the molecular diagnostics devices and equipment market from 2025–2034 with trusted insights from The Business Research Company

What Is The Present Size Of The Molecular Diagnostics Devices And Equipment Market And What Value Is Projected For 2029?

The molecular diagnostics devices and equipment market has experienced substantial growth in recent years. This market is projected to expand from $24.4 billion in 2024 to $27.23 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 11.6%. The expansion observed in the past can be attributed to a rise in funding, increased healthcare expenditure, economic growth in emerging markets, rapid technological advances, the appearance of novel pathogenic infestations, and a quickly growing geriatric population.

The market for molecular diagnostics devices and equipment is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach a valuation of $42.59 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 11.8%. Key factors contributing to this projected growth include the swift increase in bacterial and viral epidemics, an aging global demographic, enhanced access to healthcare services, the growing incidence of chronic ailments, and the surge in demand for molecular diagnostic devices and equipment prompted by COVID-19. Noteworthy trends expected during this period encompass the integration of automation into molecular diagnostics, the application of artificial intelligence, a heightened need for molecular diagnostic tools in researching rare conditions, the expanding acceptance of big data, the implementation of next-generation sequencing for newborn screenings, and the development of point-of-care molecular diagnostics (POC mdx).

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2595&type=smp

What Factors Are Boosting The Molecular Diagnostics Devices And Equipment Market?

The growing occurrence of infectious diseases is projected to boost the expansion of the molecular diagnostic devices and equipment market in the future. Infectious diseases are defined as ailments resulting from pathogenic microorganisms, including bacteria, viruses, fungi, or parasites, which possess the capability of transmission between individuals or from animals to people. The increasing frequency of infectious diseases stems from contributors like antimicrobial resistance, global mobility and travel, urban development, differences in socioeconomic status, and an aging demographic. Critical instruments for identifying and managing infectious diseases include molecular diagnostic devices and equipment. As an illustration, data from the Office for National Statistics, a UK-based government body, indicated that for the week concluding 17 March 2023, the UK registered 619 deaths linked to COVID-19, an increase from 605 in the preceding week. In the same week, fatalities due to COVID-19 constituted 4.5% of total deaths in the UK, a minor reduction from 4.6% observed the week prior. Consequently, the escalating incidence of infectious diseases is fueling the expansion of the molecular diagnostic devices and equipment market.

What Are The Core Segmentation Criteria In The Molecular Diagnostics Devices And Equipment Market?

The molecular diagnostics devices and equipmentmarket covered in this report is segmented –

1) By Product: Instruments, Reagents And Consumables, Software

2) By Technology: DNA(Deoxyribonucleic acid) sequencing, Polymerase chain reaction, Isothermal Nucleic Acid Amplification Technology, Transcription Mediated Amplification (TMA), In situ hybridization, Microarrays, Mass spectrometry, Other Technologies

3) By Application: Cancer, Pharmacogenomics, Genetic testing, Infectious disease, Prenatal, Other Applications

4) By End User: Diagnostic laboratories, Hospitals, Other End Users

Subsegments:

1) By Instruments: Polymerase Chain Reaction (PCR) Machines, Nucleic Acid Analyzers, DNA Sequencers, Microarrays

2) By Reagents And Consumables: PCR Reagents, DNA Probes And Primers, Sample Preparation Kits, Control And Calibration Materials

3) By Software: Data Analysis Software, Laboratory Information Management Systems (LIMS), Bioinformatics Software, Integration Software For Instrumentation

Which Emerging Trends Are Reshaping The Molecular Diagnostics Devices And Equipment Market Landscape?

Leading entities within the molecular diagnostic sector are concentrating on creating automated systems for the instrumentation and machinery involved in molecular diagnostic procedures. Automating these procedures is expected to boost the overall diagnostic process’s productivity and uniformity. Computerized diagnostic methods yield dependable and effective test outcomes, surpassing those achieved through manual testing by various specialists. Prominent industry participants are employing the nanotechnology-driven Oral Fluid Nano Sensor Test (OFNASET). This particular test utilizes a microfluidic nanosensor to identify oral cancer biomarkers present in saliva. Aligning with the ongoing emphasis on automation and precision, Roche developed cobas connection modules (CCM) to enhance scalability and the smooth movement of samples, enabling their automatic transfer across various systems and instruments. This effectively establishes a completely automated operational flow.

Which Players Are Shaping The Competitive Landscape Of The Molecular Diagnostics Devices And EquipmentXX Market?

Major companies operating in the molecular diagnostics devices and equipment market include F. Hoffmann-La Roche Ltd, QIAGEN N.V., Abbott Laboratories, Danaher Corporation, Biomérieux, Becton Dickinson & Co, Siemens Healthineers AG, Grifols S.A., Sysmex Corporation, Abbott India Limited, Qiagen India Pvt Ltd, Biocartis, Bio-Techne India Private Limited, Cleaver Scientific, Zhejiang Di’an Diagnostics Technology Co. Ltd, ADICON Clinical Laboratories, Guangzhou Kingmed Diagnostics Center Co. Ltd., Kindstar Global, BGI-Shenzhen, OriGene Technologies, Bayer AG, Johnson & Johnson, Nippon Becton Dickinson Company, QuantuMDx, Yourgene Health, Genefirst, Interlabservis, GeneMe, TestLine, Clinical Diagnostics s.r.o, Hologic Inc., Illumina Inc., Novartis AG, Cepheid Inc., Admera Health, Agilent technologies Inc., AutoGenomics, Bio-Red Laboratories Inc, Ortho Clinical Diagnostics Inc, Sysmex Middle East FZ-LLC, QIAGEN SA (Pty) Ltd.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/molecular-diagnostics-devices-and-equipment-global-market-report

What Regional Trends Are Shaping Growth In The Molecular Diagnostics Devices And Equipment Market?

Asia-Pacific was the largest region in the global molecular diagnostics devices (or) equipment market in 2024. Western Europe was the second largest market in molecular diagnostics devices (or) equipment market. The regions covered in the molecular diagnostics devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=2595&type=smp

Browse Through More Reports Similar to the Global Molecular Diagnostics Devices And Equipment Market 2025, By The Business Research Company

Diagnostic Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/diagnostic-equipment-global-market-report

Diagnostic Imaging Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/diagnostic-imaging-equipment-global-market-report

Point Of Care Diagnostics Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/point-of-care-diagnostics-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795